Kristin Brooks

2 weeks ago | contractpharma.com | Kristin Brooks

Navigating the complexity of today’s drug development landscape grows more challenging every day with emerging and advanced biopharmaceuticals, vast amounts of data, new technologies, and evolving regulatory requirements. Pharma and biopharma companies increasingly engage CROs to help expedite development leveraging clinical trial management, data, therapeutic, and regulatory expertise.

2 months ago | contractpharma.com | Kristin Brooks

The World Obesity Federation’s Global Obesity Observatory estimates that 1 billion adults will have obesity by 2030, and more than half of the world’s population1 will live with overweight or obesity levels by 2035. As such, there has been tremendous focus and growth in obesity drug development, with Wegovy (semaglutide) and Zepbound (tirzepatide) becoming household names in recent years.

Mar 10, 2025 | contractpharma.com | Kristin Brooks

Significant growth in demand for pharmaceuticals, such as GLP-1s, increased R&D spending for autonomous manufacturing, and the increased presence of contract manufacturers globally are among the key factors attributing to growth in the pharmaceutical manufacturing equipment market.

Dec 26, 2024 | contractpharma.com | Kristin Brooks

The past 25 years have ushered in considerable change in the industry, once dominated by small molecules to the advanced biologics and cell and gene therapies of today.

Nov 5, 2024 | insidehighered.com | Kristin Brooks |Emily E. Tichenor

November 05, 2024 South Carolina is fostering transfer excellence through institutional partnerships, making data actionable, and helping to develop a universal Transfer Explorer. You have /5 articles left. Sign up for a free account or log in. Transferring between colleges has historically been a complex, frustrating process, often involving lost credits, financial setbacks, and a lot of uncertainty for students.